Novartis AG ADR (NVS)

NYSE
Currency in USD
Disclaimer
98.13
+0.23(+0.23%)
Closed
After Hours
98.50+0.37(+0.38%)
Day's Range
97.5598.32
52 wk Range
79.98105.61
Prev. Close
97.9
Open
97.69
Day's Range
97.55-98.32
52 wk Range
79.98-105.61
Volume
1,180,063
Average Volume (3m)
1,485,489
1-Year Change
9.25%
Shares Outstanding
2,055,460,483
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
108.16
Upside +10.22%

People Also Watch

100.40
NVO
-1.41%
583.85
LLY
-1.22%
65.42
SHEL
-0.58%
223.41
DHR
+0.04%
64.79
AZN
+0.31%
How do you feel today about NVS?
Vote to see community's results!
or

Novartis AG ADR Company Profile

Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland.

Employees
103000